About | Free Trial

Last Update


This profile was last updated on // .

Is this you? Claim your profile.

Wrong Ben Lipps?

Dr. Ben Lipps J.

Chief Executive Officer

Fresenius AG

Direct Phone: (781) ***-****       

Email: b***@***.com

Fresenius AG

Else Kroner Strasse 1

Bad Homburg, Hesse 61352


Company Description

Fresenius is a health care Group with products and services for dialysis, the hospital and the medical care of patients at home. In addition, Fresenius focuses on hospital management as well as on engineering and services for hospitals and other health ca ... more

Find other employees at this company (3,719)

Background Information

Employment History

Chairman of the Management Board and Chief Executive Officer


Honorary Chairman
Supervisory Board

Honorary Chairman
Supervisory Board

Board Member
Renaissance Health Care , Inc.


Purdue University

chemical engineering
Massachusetts Institute of Technology

doctor's degree
Chemical Engineering
Massachusetts Institute of Technology

doctoral degree
chemical Engineering
Massachusetts Institute of Technology

Chemical Engineering
Massachusetts Institute of Technology

master's degree
Chemical Engineering
Massachusetts Institute of Technology

Web References (198 Total References)

Virtual Exhibit Booths

www.vbooths.com [cached]

Ben Lipps retiring as CEO of Fresenius; Rice Powell to replace him.

American Society of Nephrology | ASN Foundation for Kidney Research - Ben J. Lipps, PhD

www.asn-online.org [cached]

Ben J. Lipps, PhD American Society of Nephrology | ASN Foundation for Kidney Research - Ben J. Lipps, PhD

Ben J. Lipps, PhD
Ben J. Lipps, PhD
Ben J. Lipps, PhD, Chairman and Chief Executive Officer of the Fresenius Medical Care Management Board from 1999 to 2012, graduated from Purdue University and received masters and doctoral degrees in chemical engineering from the Massachusetts Institute of Technology (MIT).
Dr. Lipps led a research team at Dow Chemical that developed the first artificial hollow-fiber membrane for use in dialysis. This innovation reduced the blood priming volume outside the body during dialysis and enabled many more people to tolerate dialysis procedures. In the early days of dialysis, few people could tolerate the large amount of blood removed from the body during dialysis. This advance enabled more people to tolerate dialysis and is used in almost all dialyzers today.
Dr. Lipps later went into business for himself, and then in 1985 began working with the U.S. subsidiary of the German health care group Fresenius, where he was CEO of Fresenius USA until 1996.
Dr. Lipps' career exemplifies the application of scientific innovation to advance patient care. He has long emphasized the importance of researchers visiting patients in dialysis treatment facilities, and has committed a significant amount of his own time visiting with dialysis patients in the clinic setting. He considers these exchanges a primary motivator to all those involved in advancing treatment. In addition, under Dr. Lipps' leadership, Fresenius employees are provided a 24 hour hotline to allow all staff members the opportunity to suggest improvements in patient care.
At Fresenius Dr. Lipps has worked to expand dialysis care into regions where no such care has been available, and he believes the next advances in care for kidney patients will result from developing a truly integrated approach to the medical care of kidney patients worldwide.
Throughout his career, Dr. Lipps has demonstrated the ability to translate research and innovation into improved care and quality of life for patients. His innovative leadership and ability to coalesce research and clinical perspectives to improve patient care mirror the goals of the recipients of the Ben J. Lipps Research Fellowship Program.

To: Ben Lipps, CEO & ...

homedialyzorsunited.org [cached]

To: Ben Lipps, CEO & Chairman, Fresenius Medical Care

Renal Business Today - People - Page 18

www.renalbusiness.com [cached]

PETERBOROUGH, Ontario, Canada-The Peterborough Examiner reported that Fresenius Medical Care CEO Ben Lipps will travel from Germany to Peterborough on March 21 to meet a Ken Sharp, a dialysis patient who has endured 33 years of treatment.

Speech of Dr. Ben J. Lipps, ...

www.fresenius.com [cached]

Speech of Dr. Ben J. Lipps, Chairman of the Managing Board of Fresenius Medical Care AG, at the Annual General Meeting

Similar Profiles

Other People with this Name

Other people with the name Lipps

Scott Lipps
ONE Management

Don Lipps

Randall Lipps
Invuity, Inc.

Jon Lipps
Pfizer Inc

Joseph Lipps
Bailey Cavalieri LLC

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory